Barclays PLC increased its stake in DocGo Inc. (NASDAQ:DCGO – Free Report) by 279.7% during the 3rd quarter, Holdings Channel.com reports. The fund owned 134,923 shares of the company’s stock after buying an additional 99,387 shares during the period. Barclays PLC’s holdings in DocGo were worth $447,000 at the end of the most recent quarter.
A number of other institutional investors have also recently bought and sold shares of the stock. nVerses Capital LLC raised its holdings in shares of DocGo by 151.5% in the 2nd quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock worth $26,000 after purchasing an additional 5,000 shares during the period. Marathon Capital Management raised its holdings in DocGo by 2.3% in the second quarter. Marathon Capital Management now owns 277,100 shares of the company’s stock valued at $856,000 after buying an additional 6,285 shares during the period. The Manufacturers Life Insurance Company lifted its position in DocGo by 31.6% during the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock valued at $125,000 after buying an additional 9,696 shares in the last quarter. Centiva Capital LP acquired a new position in DocGo during the third quarter valued at approximately $43,000. Finally, Victory Capital Management Inc. grew its stake in DocGo by 124.0% during the second quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock worth $79,000 after buying an additional 14,191 shares during the period. 56.44% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, Cantor Fitzgerald reissued an “overweight” rating and issued a $5.00 price objective on shares of DocGo in a research report on Friday, September 20th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $6.10.
DocGo Trading Up 1.2 %
DCGO opened at $4.34 on Friday. DocGo Inc. has a twelve month low of $2.75 and a twelve month high of $5.19. The firm has a market cap of $442.90 million, a price-to-earnings ratio of 15.50, a PEG ratio of 3.94 and a beta of 0.98. The company has a fifty day simple moving average of $4.11 and a 200 day simple moving average of $3.61.
Insider Activity
In related news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction on Monday, December 16th. The shares were sold at an average price of $4.44, for a total value of $102,510.72. Following the completion of the sale, the general counsel now owns 175,645 shares in the company, valued at approximately $779,863.80. The trade was a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.70% of the company’s stock.
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Articles
- Five stocks we like better than DocGo
- Canada Bond Market Holiday: How to Invest and Trade
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- How to Buy Cheap Stocks Step by Step
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- 3 Fintech Stocks With Good 2021 Prospects
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGO – Free Report).
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.